Diamond Hill Mid Cap Strategy cites Equifax’s steady growth in essential datasets as a key driver amid broader market strength in Q2 2026.
Equifax’s consistent performance in core data segments contributed to gains in Diamond Hill Capital’s Mid Cap Strategy during Q2 2026. The fund returned 7.92%, trailing the Russell Midcap Index’s 13.83% gain but benefiting from healthcare holdings and selective exposure to high-quality companies.
Technology led sector returns, while energy lagged due to declining oil prices. The strategy avoided overvalued semiconductor and memory stocks, reflecting caution over sustained AI-driven spending. Management prioritized durable compounding and capital preservation amid elevated valuations.
Healthcare stocks, including managed care and diagnostics, were the top contributors. Limited IT exposure and stock selection weighed on relative performance, though the fund maintained a focus on long-term competitive positioning.